OKLAHOMA CITY , June 5, 2025 /PRNewswire/ -- Bank7 Corp. (NASDAQ: BSVN), the parent company of Oklahoma City-based Bank7, today announced the declaration of a quarterly cash dividend of $0.24 per share on its outstanding common stock. The dividend will be paid on July 8, 2025, to shareholders of record as of the close of business on June 20, 2025.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that David L. Hallal, Chief Executive Officer, and members of management will participate in a fireside chat at the 46th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 11 at 9:20 a.m. ET in Miami, F.

MALVERN, Pa., June 05, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today announced it will host a live webcast where Maria Maccecchini, Ph.D., President and CEO, will provide updates and answer questions from the audience.

COLUMBUS, Ohio, June 05, 2025 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding,” “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today announced that management will participate in the 15th Annual East Coast IDEAS Investor Conference at The Westin Time Square in New York City on June 11, 2025.

REYNOLDSBURG, Ohio, June 05, 2025 (GLOBE NEWSWIRE) -- Victoria's Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSCO) today announced that the Company will release first quarter 2025 financial results before market open on Wednesday, June 11th. In conjunction with the earnings release, you are invited to listen to a live webcast of the conference call on Wednesday, June 11th at 8:30 a.m.

NAARDEN, The Netherlands and MIAMI, June 05, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that it will host an R&D Day event for analysts and investors on June 11, 2025 beginning at 9:00 a.m.

BOSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that the United States District Court for the District of Massachusetts has approved the following announcement of a proposed class action settlement that would benefit purchasers of AlloVir, Inc. securities (NASDAQ: KLRS):

Innovative digital dentistry experience empowers greater efficiency, accuracy, and esthetic outcomes in dental care Innovative digital dentistry experience empowers greater efficiency, accuracy, and esthetic outcomes in dental care

HOLLYWOOD, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- NV5, a provider of tech-enabled engineering, certification, and consulting solutions, announced today that it has been selected by the National Oceanic and Atmospheric Administration (NOAA) for a five-year, multiple award contract valued at up to $250 million to provide shoreline mapping services in support of the National Geodetic Survey (NGS).

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on Wednesday, June 11th, 2025, at 9:20 a.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations.

Magnite is first SSP to integrate ContextIQ to help bring contextual targeting and planning powered by multimodal AI to CTV advertising Magnite is first SSP to integrate ContextIQ to help bring contextual targeting and planning powered by multimodal AI to CTV advertising

BOTHELL, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its broad-spectrum protease inhibitor CDI-988 will be featured in an oral presentation at the 2025 Military Health System Research Symposium (MHSRS) being held August 4-7 in Kissimmee, Fla.

Bowie, Md., June 05, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink”), a leading global owner, operator, provider, and manufacturer of electric vehicle (EV) charging equipment and services, has announced that it has named Michael Bercovich as its new Chief Financial Officer. Bercovich, who will officially assume the CFO role at Blink on June 23rd, previously served as Chief Financial Officer at Helios Global Payments Solutions, MyOutDesk, Cialfo and Elements Global Services, where he led variety of functions, such as finance and operations, corporate development, investor relations, treasury, and strategic initiatives including fundraising.

KIRKLAND, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.

Denver, Colorado, June 05, 2025 (GLOBE NEWSWIRE) -- authID, a leading provider of identity proofing and biometric authentication, today announced a new integration with Ping Identity, a leader in securing digital identities for the world's largest enterprises. authID will leverage PingOne DaVinci™, a no-code identity orchestration service, enabling organizations to quickly and easily adopt privacy-preserving biometrics, which will help them eliminate the need for passwords and mitigate account takeover fraud.

Access the on-demand webcast here HOUSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, today announced the release of its Soft Tissue Sarcoma (STS) Lung Mets KOL Webcast discussing the final data from its U.S. Phase 1B/2 clinical trial evaluating Annamycin as monotherapy for the treatment of soft tissue sarcoma lung metastases (MB-107). For the event, Walter Klemp, Chairman and Chief Executive Officer, and Dr. Paul Waymack, Senior Chief Medical Officer of Moleculin are joined by Key …

EMA Orphan Drug Designation (ODD) builds on U.S. Food & Drug Administration (FDA) ODD and Fast Track Designation, underscoring the urgent need for new treatment options The multiple regulatory designations were granted following strong positive results from a global randomized Phase 1b/2 study in first-line HCC demonstrating superior outcomes for amezalpat combination therapy across multiple study endpoints, including overall survival in both the entire population and key subpopulations, when compared to standard of care alone BRISBANE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated …

VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces the launch of Drone as a Service specifically for US Defense and Government agencies, and two new partnerships with consulting and government relations firms to assist in selling these services. ZenaTech's ZenaDrone subsidiary has retained the services of Bromelkamp Government Relations and Winning Strategies Washington to provide Congressional lobbying and defense business development consulting services.

MCLEAN, Va. & LONDON--(BUSINESS WIRE)--To celebrate 20 years of partnership, Hilton and McLaren Racing are introducing a “Stay Like McLaren Racing” suite in London. Combining world-class hospitality and pit lane power, beginning today, racing fans can book their dream stay from July 8-20, 2025, at The Trafalgar St. James London, Curio Collection by Hilton, just in time for the Formula 1 British Grand Prix at Silverstone. Rooted in Hilton's “It Matters Where You Stay” campaign, the “Stay Like Mc.

Singapore , June 05, 2025 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) (“YY Group”, “YYGH”, or the “Company”), is pleased to announce the acquisition of Uniforce Security Pte Ltd (UFS), marking a pivotal step in expanding the Company's Integrated Facility Management (IFM) division. This strategic acquisition underscores the Company's commitment to delivering comprehensive, cutting-edge solutions to clients worldwide.